| Type | Title | Date Released | |
|---|---|---|---|
4 | BERMAN MICHAEL (Reporting) | ||
4 | ROUBIN GARY S (Reporting) | ||
4 | Stuka Paul (Reporting) | ||
8-K | InspireMD Announces Warrant Amendments for Potential Gross Proceeds of Up to $11 Million | ||
8-K | InspireMD Reports Second Quarter 2026 Financial Results | ||
10-Q | Form 10-Q | ||
8-K | InspireMD, Inc. Announces Departure of Chief Commercial Officer | ||
8-K | InspireMD, Inc. Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price | ||
8-K | InspireMD, Inc. Announces Resignation of Director Raymond W. Cohen | ||
8-K | InspireMD Announces Positive 30-Day Results from CGUARDIANS II Clinical Trial for CGuard Prime 80 cm Implant | ||
8-K | InspireMD, Inc. Announces Results of 2026 Annual Meeting of Stockholders | ||
4 | Stuka Paul (Reporting) |